Neuroleptics and bone mineral density.
al-Adwani
A
A
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000191:economics / Q000209:etiology; D017048:Health Care Costs; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000150:complications*; D010024:Osteoporosis / Q000191:economics / Q000209:etiology*
D014150:Antipsychotic Agents